A hands-on look at the world of pharma: National Future Day at AstraZeneca in Baar

What does everyday working life look like at a pharmaceutical company? What happens in research, what does Market Access do, and what role does artificial intelligence really play? 34 children explored these questions during the National Future Day at AstraZeneca and Alexion in Baar. Among them this year were five Ukrainian children from the asylum and refugee centres Lorzenmatt in Zug and Waldheim in Risch-Rotkreuz.

The National Future Day aims to spark curiosity and open up new perspectives. That was precisely the focus at AstraZeneca in Baar: “Curiosity is the best starting point for any career path. On Future Day, children have the opportunity to try out new things with us, ask questions, and explore a wide variety of different fields. We want to show them what is possible and encourage them to pursue their own interests,” says Katrin Lipp, HR Lead at AstraZeneca Switzerland.

The Long Journey of a Medicine – Brought to Life Through Play

What does it really take for a medicine to reach patients? The children approached this question from many different angles. At various interactive stations, they learned how research and clinical trials are conducted, how a medicine receives regulatory approval, and how it ultimately becomes part of medical care. They also gained insights into our commitment to patients, the significance of innovation in the pharmaceutical industry, and how research and development are financed.

New Insights, Shared Experiences

This year’s group of participants included a special highlight: alongside children of employees, five Ukrainian children from the asylum and refugee centres Lorzenmatt in Zug and Waldheim in Risch-Rotkreuz joined AstraZeneca’s Future Day. One of them was Oleksandr Kudrevych, who particularly remembered the diverse programme: “I found the AI session and an experiment with gummy bears especially exciting. We were able to try out a lot of things ourselves, were constantly on the move, and saw so many different things.”

Guiding Young Talents on Their Journey into Science

Gaining early insights as a child can pave the way toward a future career in science. For AstraZeneca, fostering young talent therefore does not end with Future Day. Through a range of initiatives, the company aims to give young people insight into science and pharmaceuticals and accompany them through different stages of their educational and career journeys. This includes the Early Talent Programme for Master’s and PhD graduates, in which participants spend 18 months exploring various areas of the business.



Media contact

Tel. +41 (0) 41 725 75 75; media.switzerland@astrazeneca.com

Barbara Hess, Corporate Communications Lead, AstraZeneca Switzerland

 

AstraZeneca in Switzerland

AstraZeneca is a global, research-driven biopharmaceutical company that has been active in Switzerland for nearly 50 years and ranks among the ten largest pharmaceutical companies in the country by revenue. AstraZeneca researches, develops, and markets prescription medicines primarily in the areas of oncology; cardiovascular, renal and metabolism; respiratory and immunology; and rare diseases. More than 280 employees in Switzerland are committed to improving the lives of patients with innovative therapies and making a positive contribution to the healthcare system, society, and the planet. Currently, over 275,000 people in Switzerland are treated with an AstraZeneca medicine. Between 2026 and 2028, the company expects the approval of 40 new therapies. AstraZeneca is clearly committed to a working environment based on respect and acceptance. In 2025, the company was recognised as a "Great Place to Work" for the seventh consecutive year and carries the "Swiss LGBTI Label". By 2045, AstraZeneca aims to be carbon negative.

More information about AstraZeneca Switzerland: www.astrazeneca.ch